Anxiety Disorder Clinical Trials 2023

What are the top hospitals conducting anxiety disorder research?

When it comes to advancing our understanding and treatment of anxiety disorders, several top hospitals are leading the way with their groundbreaking clinical trials. Massachusetts General Hospital in Boston, a renowned institution in mental health research, currently has four active trials focused on anxiety disorders. Their dedication to this field is evident through their impressive track record of 31 completed trials since recording their first study back in 2003. Meanwhile, the Michael E. DeBakey VA Medical Center located in Houston, Texas is making significant contributions as well with three ongoing anxiety disorder trials and a total of six completed studies since initiating their first trial in 2002.

In New york City, The Medical Research Network LLC is actively involved in three anxiety disorder trials that aim to provide new insights into this complex condition. While they may have fewer overall trials compared to other institutions (with only four recorded), their commitment towards cutting-edge research shines through despite joining the field more recently with their initial trial taking place just ten years ago in 2011.

North of the border, Toronto Western Hospital plays an important role by currently conducting two active clinical trials centered around anxiety disorders. Although they may be relatively new to exploring these specific conditions (having commenced their inaugural trial slated for completion in2023) there is no denying the potential impact they can make towards improving outcomes for individuals affected by such disorders

Lastly but not leastly,in Kingston Ontario; Kingston Health Sciences Centre has joined efforts focusing anxieties debilitating effects via participating on present-day's two promising clinical endeavors while also having been committed enough earlier when holding previous pair investigations during year2009.

These remarkable hospitals symbolize true pillars within psychiatric research; propelling advancements that pave pathways toward better diagnosis methods enhanced therapeutic approaches which ultimately promises brighter future where millions living with anxieties could obtain relief from distresses associated with aforementioned conditions

Which are the best cities for anxiety disorder clinical trials?

When it comes to anxiety disorder clinical trials, several cities emerge as leading centers for research and development. Boston, Massachusetts tops the list with 11 active trials investigating various interventions like Daylight dCBT Application, Naproxen Sodium, and IntelliCare with Automated Motivational Messaging and Coach Support. Following closely behind are Houston, Texas and New york City, both offering 8 ongoing studies exploring treatments such as iTCBT-I (Intensive Transdiagnostic Cognitive Behavioral Therapy-Individual), Structured games, Clinician-delivered CBT + Supplemental app, and Cariprazine. Toronto in Ontario also shows promise with 7 active trials examining interventions like Physical Activity Program + General Health Education Materials and Group 1: VR-ET. Lastly, Austin, Texas showcases 5 active trials focused on interventions including Focused ultrasound and Interoceptive Exposure. These cities serve as beacons of hope for individuals seeking innovative approaches to managing anxiety disorders through participation in clinical trials that pave the way for improved treatment options.

Which are the top treatments for anxiety disorder being explored in clinical trials?

Clinical trials are continuously exploring new avenues to find effective treatments for anxiety disorders. One treatment that shows promise is Omnis Salutis, currently being investigated in one active trial specifically dedicated to anxiety disorder. Although it has only recently been listed in 2023 and has a limited number of trials thus far, the potential benefits it may offer individuals struggling with anxiety make it an exciting area of research. As we delve deeper into these clinical trials, we hope to uncover groundbreaking advancements that will bring relief to those affected by anxiety disorders worldwide.

What are the most recent clinical trials for anxiety disorder?

Exciting developments in the field of anxiety disorder research have yielded promising clinical trials. Inositol, a substance undergoing Phase 1 and Phase 2 studies, has shown potential as a treatment option for individuals with anxiety disorders. Another trial focuses on ABBV-932, which is currently in Phase 1 testing and aims to evaluate its efficacy in managing anxiety disorder symptoms. Additionally, ENX-102 is being investigated during its Phase 2 stage to determine its suitability as an intervention for anxiety disorders. The use of cannabidiol is also under scrutiny through a Phase 4 study to explore its effects on alleviating anxiety disorder symptoms. Finally, SEP-363856's phases 2 and 3 are underway to assess this compound's effectiveness against these debilitating conditions. These exciting advancements provide hope for improved treatments that can enhance the lives of those impacted by anxiety disorders.

What anxiety disorder clinical trials were recently completed?

Recent clinical trials have made significant progress in the field of anxiety disorder research. In May 2022, Receptor Life Sciences concluded a trial investigating the effectiveness of Low dose RLS103 therapy. Likewise, Bionomics Limited completed their study on the potential benefits of 225 mg BNC210 in February 2022. The year prior, VistaGen Therapeutics successfully wrapped up their trial on PH94B Nasal Spray in May 2021. These studies demonstrate ongoing efforts to advance our understanding and treatment options for individuals living with anxiety disorders.